5,400
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Impact of venetoclax monotherapy on the quality of life of patients with relapsed or refractory chronic lymphocytic leukemia: results from the phase 3b VENICE II trial

ORCID Icon, ORCID Icon, ORCID Icon, , , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , ORCID Icon, , & ORCID Icon show all
Pages 304-314 | Received 28 Jun 2021, Accepted 20 Sep 2021, Published online: 11 Oct 2021